Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now small index

Structural Heart Disease clinical trials

1 of 3 indexed Structural Heart Disease trials are currently recruiting.

Corpus placement: #5,209 of 28,707 conditions by registered trial count.

3 US clinical trials · 1 currently recruiting · #5,209 of 28,707 conditions by registered trial count

Structural Heart Disease: 3 US clinical trials tracked, 1 recruiting.

Structural Heart Disease is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. The most active sponsor is Tempus AI, running 1 of these trials.

Enrollment posture brief

Registry condition structural-heart-disease

OPEN 1 | RECR 33% | LATE 0 | EARLY 0 | RANK #5209 | SPON 1

Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Structural Heart Disease (th…33%
Open-enrollment share among volume-matched conditions near Structural Heart Disease

Structural Heart Disease lists 1 open slots (33% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Structural Heart Disease on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Structural Heart Disease is recruiting below its size-band peers.

    1 of 3 indexed trials (33.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase Distribution

Phase data not available

Top Sponsors

Tempus AI 1 trials
Eko Devices 1 trials

Named interventions

Most-linked intervention names on Structural Heart Disease records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Transesophageal Echocardiography/angiography (TEE/Angio) Device
1 trials
Echocardiogram Device
1 trials
Zio Patch Monitor Device
1 trials
Eko digital stethoscopes Device
1 trials

US sites by state

Facility locations filed on Structural Heart Disease trials. A trial with sites in several states counts in each.

Pennsylvania 1 trials
Ohio 1 trials
New York 1 trials
Missouri 1 trials
Michigan 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Structural Heart Disease page

3 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 Structural Heart Disease trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Tempus AI sponsors the most Structural Heart Disease trials on record, review their full trial history before evaluating a specific study. See Tempus AI's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Structural Heart Disease condition card totals 3 registered trials; most-linked intervention Transesophageal Echocardiography/angiography (TEE/Angio); top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.